COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04558203
Recruitment Status : Recruiting
First Posted : September 22, 2020
Last Update Posted : September 24, 2020
Information provided by (Responsible Party):

Brief Summary:
The study explore the relationship between COVID-19 and the induction of autoimmune diseases.

Condition or disease

Detailed Description:
It has been suggested that the shared pathogenetic mechanisms and clinical-radiological aspects between the hyper-inflammatory diseases and Covid-19 may suggest that SARS-CoV-2 could act as a triggering factor for the development of a rapid autoimmune and/or autoinflammatory dysregulation, leading to the severe interstitial pneumonia, in genetic predisposed individuals.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 450 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 2 Weeks
Official Title: The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
Actual Study Start Date : September 22, 2020
Estimated Primary Completion Date : October 25, 2020
Estimated Study Completion Date : October 30, 2020

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. incidence of autoimmune conditions [ Time Frame: Two-weeks ]
    incidence of autoimmune conditions

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
the study population are all patients came to the center with symptoms and signs suspected to be COVID-19

Inclusion Criteria:

  • COVID-19 cases

Exclusion Criteria:

  • not proved to be COVID-19 cases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04558203

Layout table for location contacts
Contact: Emad R Issak, MD 01272228989

Layout table for location information
Asalam Recruiting
Maadi, Cairo, Egypt, 11433
Contact: Emad R Issak, MD    01272228989   
Sponsors and Collaborators
Layout table for investigator information
Principal Investigator: Emad R Issak, MD Asalam Center
Layout table for additonal information
Responsible Party: ClinAmygate Identifier: NCT04558203    
Other Study ID Numbers: PR0014
First Posted: September 22, 2020    Key Record Dates
Last Update Posted: September 24, 2020
Last Verified: September 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Autoimmune Diseases
Immune System Diseases